• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

    6.855 +0.135 (+2.01%)
    Streaming Delayed Price Updated: 3:43 PM EDT, Apr 28, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Treace Medical Concepts, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
    Positions Treace to Significantly Increase Penetration into Overall Bunion Market and Expand Surgeon Customer Base 
    From Treace Medical Concepts, Inc.
    Via GlobeNewswire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
    Via Benzinga
    Unveiling 6 Analyst Insights On Treace Medical Concepts
    Via Benzinga
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
    From Treace Medical Concepts, Inc.
    Via GlobeNewswire
    TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
    From Treace Medical Concepts, Inc.
    Via GlobeNewswire
    Treace Medical Concepts Reports Second Quarter 2024 Financial Results
    From Treace Medical Concepts, Inc.
    Via GlobeNewswire
    Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024
    From Treace Medical Concepts, Inc.
    Via GlobeNewswire
    3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
    Insiders are buying the dips in these three stocks, which suggests a rebound is coming. There are reasons the market dipped, but the sell-offs are overdone. 
    Via MarketBeat
    Topics Initial Public Offering
    Exposures Securities Market
    Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
    From Treace Medical Concepts, Inc.
    Via GlobeNewswire
    TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
    Via Benzinga
    TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)
    From Kirby McInerney LLP
    Via Business Wire
    Orthopedic Devices Maker Treace Medical Concepts' Gloomy Forecast Cast Concerns Over Long-Term Viability
    Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted... 
    Via Benzinga
    Dow Gains 150 Points; Emerson Electric Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Crude Oil Moves Higher; Inspire Medical Systems Shares Plummet
    Via Benzinga
    Exposures Fossil Fuels
    Nasdaq Down Over 50 Points; Uber Posts Q1 Loss
    Via Benzinga
    Why Is DoubleVerify (DV) Stock Down 39% Today?
    DoubleVerify stock is falling on Wednesday as DV shareholders are disappointed by the company's weak guidance in its Q1 earnings report. 
    Via InvestorPlace
    Why Is Treace Medical Concepts (TMCI) Stock Down 59% Today?
    Treace Medical Concepts stock is falling on Wednesday as investors in TMCI shares react to a poor guidance in its latest earnings report. 
    Via InvestorPlace
    Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    We're diving into the biggest pre-market stock movers for Wednesday will a look at all of the latest news happening this morning. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.